Potential AVE Long position!!SMP TRADING
SELF DEVELOPMENT/METHODOLOGY/PSYCHOLOGY
SMP Strategy
Market Direction: Long Position
Chart time frame - Daily
Timeframe - 30 days
A – Activating Event
Market will meet support in zone @ current levels - ... . In order to enter into this trade, the pair MUST be in line with my
−0.002AUD
−3.44 MAUD
473.55 KAUD
2.60 B
About AVECHO BIOTECHNOLOGY LIMITED
Sector
CEO
Paul David Gavin
Headquarters
Clayton
Website
Founded
1992
ISIN
AU0000047441
FIGI
BBG000KD38P0
Avecho Biotechnology Ltd. engages in the development and commercialization of human and animal products through its proprietary drug delivery system. It operates under the Production and Human Health segments. The Production segment focuses on manufacturing and sale of TPM and Vital ET for the use in drug delivery and cosmetic formulations. The Human Health segment consists of delivery of pharmaceutical products through gels, injectables and patches including conduct of research and development activities. The company was founded by Mark Gregory Kerr on June 19, 1992 and is headquartered in Clayton, Australia.
AVE LongBought into AVE a couple of weeks ago on 4/12/2020 at 0.014. So far I am happy with its progress.
Trialing a trailing sell technique with this one.
ENTRY: 0.014
Original STOPLOSS: 0.012
Adjusted STOP LOSS: 0.019
Resistance level expected around 0.026 - 0.033
Conservative Target = 0.026 - 0.033
See all ideas
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.
Frequently Asked Questions
The current price of AVE is 0.005 AUD — it has increased by 25.00% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on ASX exchange AVECHO BIOTECHNOLOGY LIMITED stocks are traded under the ticker AVE.
AVECHO BIOTECHNOLOGY LIMITED is going to release the next earnings report on Aug 29, 2024. Keep track of upcoming events with our Earnings Calendar.
AVE stock is 25.00% volatile and has beta coefficient of 1.54. Check out the list of the most volatile stocks — is AVECHO BIOTECHNOLOGY LIMITED there?
Yes, you can track AVECHO BIOTECHNOLOGY LIMITED financials in yearly and quarterly reports right on TradingView.
AVE stock has risen by 25.00% compared to the previous week, the last month showed zero change in price, over the last year there was no change in AVECHO BIOTECHNOLOGY LIMITED price.
AVE net income for the last quarter is −1.31 M AUD, while the quarter before that showed −2.13 M AUD of net income which accounts for 38.47% change. Track more AVECHO BIOTECHNOLOGY LIMITED financial stats to get the full picture.
No, AVE doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
Like other stocks, AVE shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade AVECHO BIOTECHNOLOGY LIMITED stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So AVECHO BIOTECHNOLOGY LIMITED technincal analysis shows the strong buy rating today, and its 1 week rating is buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating AVECHO BIOTECHNOLOGY LIMITED stock shows the sell signal. See more of AVECHO BIOTECHNOLOGY LIMITED technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. AVECHO BIOTECHNOLOGY LIMITED EBITDA is −4.41 M AUD, and current EBITDA margin is −931.37%. See more stats in AVECHO BIOTECHNOLOGY LIMITED financial statements.